Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma | Oncohema Key
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Full article: Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal
Comparison of classic IPI, NCCN-IPI, and modified prognostic model for... | Download Table
![PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5835aee9687d11160fd503ad0ecb876e36789aca/3-Table1-1.png "PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar")
PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
British Journal of Haematology | Wiley Online Library
Application of the Central Nervous System International Prognostic Index ( CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil - ScienceDirect
![PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/590fd910655ba40d90e40e5a20cdca99feb35b07/6-Table3-1.png "PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar")
PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar
![PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/590fd910655ba40d90e40e5a20cdca99feb35b07/3-Table1-1.png "PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar")
PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar
Percentage of 122 non-HDMTX and 24 HDMTX patients with total CNS-IPI... | Download Scientific Diagram
Jeremy Pantin (@JeremyPantinMD) / X
Diffuse Large B-cell Lymphoma Prognosis Calculator
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients
PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu
PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu
1876-CNS prophylaxis in diffuse large B cell lymphoma | eviQ
Baseline patient characteristics by CNS-IPI score | Download Table
Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review - ScienceDirect
Outcomes of high‑dose methotrexate for CNS prophylaxis in diffuse large B‑cell lymphoma with an intermediate or high CNS‑International Prognostic Index: A single‑center retrospective cohort study
